Similarly, the current ASA consensus-based guidance statement on preoperative management of patients taking GLP-1 agonists advocates for patients undergoing elective procedures to hold these medications 1 week preoperatively and to evaluate patients for symptoms that could put them at increased risk of gastroparesis (e.g., nausea, bloating, or abdominal pain). The gene discussed is GLP1R; the disease is gastroparesis.